Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

7.76USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$7.76
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,257
52-wk High
$21.59
52-wk Low
$7.22

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.816
Jun '17 0.00 -0.990
Mar '17 0.00 -0.787
FY 2016 Dec '16 0.00 -0.306
Sep '16 0.00 -0.565
Jun '16 0.00 -0.166
Mar '16 0.00 -0.267
FY 2015 Dec '15 0.00 -0.447
Sep '15 0.00 -0.135
Jun '15 0.00 -0.596
Mar '15 0.00 -0.569
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 0.00 0.00 0.00 0.00
Quarter Ending Mar-18 3 0.00 0.00 0.00 --
Year Ending Dec-17 4 0.00 0.00 0.00 0.00
Year Ending Dec-18 5 0.88 4.38 0.00 0.83
Earnings (per share)
Quarter Ending Dec-17 4 -0.72 -0.54 -0.86 -0.50
Quarter Ending Mar-18 3 -0.76 -0.70 -0.85 -1.00
Year Ending Dec-17 4 -3.31 -3.13 -3.46 -1.93
Year Ending Dec-18 5 -2.72 -1.99 -3.84 -2.76
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 188.50 35.37
P/E High - Last 5 Yrs. -- 275.44 45.18
P/E Low - Last 5 Yrs. -- 92.47 24.20
Beta -- 0.82 0.91
Price to Sales (TTM) -- 113.76 5.84
Price to Book (MRQ) 8.17 21.88 5.65
Price to Tangible Book (MRQ) 8.17 25.71 7.25
Price to Cash Flow (TTM) -- 102.10 24.30
% Owned Institutions 31.60 5.62 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 1.99 5.25
Payout Ratio(TTM) -- 97.35 46.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- -3.12 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 30.10 5.63
Sales - 5 Yr. Growth Rate -- 33.18 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -44.49 -148.25 7.98
EPS (TTM) vs TTM 1 Yr. Ago -100.69 -- --
EPS - 5 Yr. Growth Rate -- 43.65 10.92
Capital Spending - 5 Yr. Growth Rate -- 40.96 15.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 4.16 5.70 3.56
LT Debt to Equity (MRQ) 100.15 14.49 13.37
Total Debt to Equity (MRQ) 100.15 16.95 19.40
Interest Coverage (TTM) -- -138.10 44.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 43.91 54.89
Gross Margin - 5 Yr. Avg. -- 55.68 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -215.89 15.52
Operating Margin (TTM) -- -626.98 6.76
Operating Margin - 5 Yr. Avg. -- -232.77 11.02
Pre-Tax Margin (TTM) -- -597.81 7.58
Pre-Tax Margin - 5 Yr. Avg. -- -233.06 11.42
Net Profit Margin (TTM) -- -595.34 3.81
Net Profit Margin - 5 Yr. Avg. -- -236.34 7.71
Effective Tax Rate (TTM) -- 15.36 24.25
Effective Tax Rate - 5 Yr. Avg. -- 18.92 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,716,698 852,152,758
Net Income/Employee (TTM) -2,117,688 -1,723,651 99,529,045
Receivable Turnover (TTM) -- 26.31 6.14
Inventory Turnover (TTM) -- 2.63 3.55
Asset Turnover (TTM) 0.00 0.42 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -122.91 -9.30 11.32
Return on Assets - 5 Yr. Avg. -- 0.22 12.29
Return on Investment (TTM) -144.48 -11.67 14.45
Return on Investment - 5 Yr. Avg. -- 3.35 16.09
Return on Equity (TTM) -183.46 -36.21 16.05
Return on Equity - 5 Yr. Avg. -- 5.77 17.30
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -66.37 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Gemphire Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 31.60%
# of Holders: 32
Total Shares Held: 3,359,800
3 Mo. Net Change: 244,914
# New Positions: 7
# Closed Positions: 7
# Increased Positions: 17
# Reduced Positions: 16
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.